01/15
Headlines

NASDAQ:CMRX

Investors Watch List : Mylan, Inc. (NASDAQ:MYL), Chimerix, Inc. (NASDAQ:CMRX), Universal Display Corp. (NASDAQ:OLED), Luxottica Group SpA (NYSE:LUX), Baytex Energy Corp. (NYSE:BTE)

Ryan Holtz02 mins

Mylan, Inc. (NASDAQ:MYL) has become the target of anti-death penalty campaigners with a German investment fund selling its shares in the pharmaceuticals group because of concern that one of its products could be used in executions by American prisons. Mylan, Inc. (NASDAQ:MYL) belongs to Healthcare sector. Its net profit margin is 8.10% and weekly performance…

Read More

Best Stocks : General Electric Company (NYSE:GE), J. C. Penney Company (NYSE:JCP), J&J Snack Foods Corp. (NASDAQ:JJSF), Chimerix, Inc. (NASDAQ:CMRX), Polycom (NASDAQ:PLCM)

Colin Pettis03 mins

Organization in focus has been General Electric Company (NYSE:GE), well-known as GE, and on being questioned by CNBC on its future prospects, vice president John Rice painted a rosy picture liberally doused with optimism. Much of his positive outlook was based on the fact that infrastructure as the company’s core business is likely to herald…

Read More

Whats Hot Today : Agnico Eagle Mines (NYSE:AEM), Altair Nanotechnologies (NASDAQ:ALTI), Chimerix (NASDAQ:CMRX), Redwood Trust, Inc. (NYSE:RWT), Dril-Quip (NYSE:DRQ)

Jayne Crisman03 mins

Agnico Eagle Mines Limited (NYSE:AEM) announced the filing of a technical report in respect of the Canadian Malartic mine. Agnico Eagle and Yamana Gold Inc (“Yamana”) each acquired a 50% interest in the mine as part of the joint acquisition of Osisko Mining Corporation, which was completed on June 16, 2014.  The mine is operated by…

Read More

Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

Jayne Crisman03 mins

On May 9, 2014, Amicus Therapeutics, Inc. (NASDAQ:FOLD) updated its Investor Presentation for the Migalastat Monotherapy Program (the “Presentation”). The Company’s Chief Financial Officer, William D. Baird III and the Company’s Chief Operating Officer, Bradley L. Campbell, will present some or all of this Presentation to various investors in the coming months. A copy of…

Read More
FB Nasdaq FB Facebook

Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

John Bellich02 mins

Chimerix Inc. (NASDAQ:CMRX) shares hit a new high on Thursday with the biotechnology firm continuing to get a boost from its decision to increase a test program for a virus-fighting drug so it can try to save a cruelly ill 7-year-old boy. Chimerix Inc. (NASDAQ:CMRX) stock performance was 2.80% in last session and finished the…

Read More
FB Nasdaq FB Facebook

Biotech Most Volatile Stocks: Opexa Therapeutics (NASDAQ:OPXA), Intrexon (NYSE:XON), Chimerix (NASDAQ:CMRX), NewLink Genetics (NASDAQ:NLNK)

Colin Pettis02 mins

On March 5, 2014, Opexa Therapeutics, Inc. (NASDAQ:OPXA) entered into a First Amendment to Sales Agreement (the “First Amendment”) with Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P.) (the “New Sales Manager”) and Brinson Patrick Securities Corporation (the “Original Sales Manager”). Pursuant to the First Amendment, the Sales Agreement…

Read More